Clinical Trial Update: SBRT in HCC With Oligoprogression on First-line Immunotherapy [NA]

View source ↗

Summary

A clinical trial evaluating stereotactic body radiotherapy for hepatocellular carcinoma patients with oligoprogression on first-line immunotherapy; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SBRT (stereotactic body radiotherapy)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: HCC | NA | Status: RECRUITING